WEBINAR
Despite many years of research, relatively little is known about destructive neurodegenerative diseases such as Parkinson’s, ALS, and Alzheimer’s. Traditional methods, like short-read sequencing and microarray data, often miss critical genetic information such as structural variants, repeat expansions, methylation, and RNA isoforms—all key in driving new discoveries and identifying therapeutic targets.
In this webinar, learn about the sequencing technology that is pushing neuroscience research forward, particularly in Parkinson’s disease. Discover how HiFi whole genome sequencing (WGS) and the PacBio Iso-Seq method provide complete visibility into all genomic variants, reveal crucial transcript isoform information, and ultimately enable the potential development of novel therapeutics.
Register to:
Don’t forget to stick around and have your questions answered during a live Q&A session!
Register for webinar
Mina Ryten, MD, PhD
Clinical Professor, Honorary Consultant Clinical Geneticist, University College London, Genetics & Genomic Medicine Dept.
The splice of life: Targeting SNCA transcripts to treat Parkinson's disease
Nicole Ellis-Ovadia
Associate Director, Human Genomics, PacBio
Introductory remarks
Nadia Sellami, PhD
Segment Lead, Biopharma, PacBio
Host & moderator